ATR

AptarGroup, Inc. NYSE

Healthcare ·Medical - Instruments & Supplies ·US · aptar.com

$119.02

After hrs $120.60 -0.02%

Mkt Cap $7.9B

52w Low $103.23 25.9% of range 52w High $164.28

50d MA $130.86 200d MA $131.15

P/E (TTM) 19.9x

EV/EBITDA 11.0x

P/B 2.9x

Debt/Equity 0.6x

ROE 14.7%

P/FCF 26.8x

RSI (14) —

ATR (14) —

Beta 0.49

50d MA $130.86

200d MA $131.15

Avg Volume 528.1K

About

AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhal…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Apr 30, 2026	AMC	1.15	1.19	+3.5%	123.68	+2.9%	-3.8%	—	—	—	—	—	—
Feb 5, 2026	AMC	1.24	1.25	+0.8%	123.98	+2.9%	+8.3%	+11.7%	+13.1%	+12.9%	+13.3%	+7.9%	—
Oct 30, 2025	AMC	1.57	1.62	+3.2%	124.36	-7.3%	-6.7%	-9.0%	-8.2%	-7.1%	-6.6%	-0.9%	—
Jul 31, 2025	AMC	1.58	1.66	+5.1%	157.14	-0.1%	-10.0%	-11.5%	-10.8%	-11.8%	-10.6%	-13.2%	—
May 1, 2025	AMC	1.16	1.20	+3.4%	148.28	+3.2%	+2.5%	+2.2%	+1.8%	+2.1%	+3.4%	+5.8%	—
Feb 6, 2025	AMC	1.28	1.52	+18.8%	156.45	+0.7%	-8.5%	-8.4%	-9.1%	-9.4%	-8.7%	-3.8%	—
Oct 24, 2024	AMC	1.42	1.49	+4.9%	166.55	+1.4%	+1.4%	+1.5%	+1.3%	+1.5%	+0.8%	+3.6%	—
Jul 25, 2024	AMC	1.36	1.37	+0.7%	141.49	+1.2%	+3.7%	+4.5%	+3.0%	+3.9%	+3.9%	+6.1%	—
Apr 25, 2024	AMC	1.15	1.26	+9.6%	140.18	+1.3%	+2.2%	+4.4%	+3.0%	+3.7%	+4.1%	+4.7%	—
Feb 8, 2024	AMC	1.12	1.21	+8.0%	132.12	-0.0%	+5.2%	+4.2%	+2.9%	+3.8%	+2.2%	+8.0%	—
Oct 25, 2023	AMC	1.27	1.39	+9.4%	122.37	-0.9%	+0.9%	-1.0%	-0.2%	-0.1%	+0.5%	+5.0%	—
Jul 27, 2023	AMC	1.14	1.23	+7.9%	119.14	+2.8%	+3.9%	+1.9%	+2.8%	+2.6%	+1.4%	+8.6%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Mar 20	Wells Fargo	Upgrade	Equal Weight → Overweight	—	$123.97	$124.26	+0.2%	-2.3%	+0.1%	+0.1%	+1.5%	+0.6%
Jan 6	Wells Fargo	Downgrade	Overweight → Equal Weight	—	$123.00	$122.22	-0.6%	-2.0%	-2.1%	-0.5%	+0.7%	+1.7%
Nov 3	Baird	Maintains	Outperform → Outperform	—	$116.01	$116.09	+0.1%	-2.5%	-1.6%	-0.4%	+0.1%	+0.2%
Nov 3	Wells Fargo	Maintains	Overweight → Overweight	—	$116.01	$116.09	+0.1%	-2.5%	-1.6%	-0.4%	+0.1%	+0.2%
Sep 10	Wells Fargo	Maintains	Overweight → Overweight	—	$137.05	$136.13	-0.7%	-0.6%	+0.0%	-1.3%	-1.6%	-1.3%
Aug 4	Raymond James	Maintains	Outperform → Outperform	—	$141.35	$143.12	+1.3%	-1.6%	-0.8%	-2.0%	-0.6%	-0.4%
Aug 4	Wells Fargo	Maintains	Overweight → Overweight	—	$141.35	$143.12	+1.3%	-1.6%	-0.8%	-2.0%	-0.6%	-0.4%
Jul 18	Wells Fargo	Maintains	Overweight → Overweight	—	$156.03	$156.85	+0.5%	+0.2%	-0.4%	+2.0%	+3.6%	+3.7%
Jul 15	Raymond James	Maintains	Outperform → Outperform	—	$157.56	$157.74	+0.1%	-2.2%	-1.6%	-1.0%	-0.7%	-1.3%
May 6	Wells Fargo	Maintains	Overweight → Overweight	—	$151.48	$150.25	-0.8%	-0.4%	-0.1%	+1.2%	+1.2%	+2.7%
Apr 22	Raymond James	Maintains	Outperform → Outperform	—	$142.58	$144.50	+1.3%	+2.4%	+3.8%	+6.2%	+4.5%	+5.0%
Feb 10	Raymond James	Maintains	Outperform → Outperform	—	$143.18	$144.26	+0.8%	+0.1%	-0.6%	-1.0%	-0.3%	+1.1%
Feb 10	Wells Fargo	Maintains	Overweight → Overweight	—	$143.18	$144.26	+0.8%	+0.1%	-0.6%	-1.0%	-0.3%	+1.1%
Feb 10	Baird	Maintains	Outperform → Outperform	—	$143.18	$144.26	+0.8%	+0.1%	-0.6%	-1.0%	-0.3%	+1.1%
Jan 6	Wells Fargo	Maintains	Overweight → Overweight	—	$155.50	$154.00	-1.0%	-1.7%	-1.3%	-0.9%	-1.3%	-1.0%
Oct 28	Baird	Maintains	Outperform → Outperform	—	$168.91	$169.90	+0.6%	+0.1%	-0.1%	+0.1%	-0.6%	+0.3%
Oct 15	Wells Fargo	Maintains	Overweight → Overweight	—	$167.19	$167.32	+0.1%	+0.9%	-0.7%	+0.4%	+0.9%	-0.5%
Oct 14	Jefferies	Upgrade	Hold → Buy	—	$161.55	$164.99	+2.1%	+3.5%	+4.4%	+2.8%	+3.9%	+4.4%
Jul 17	Wells Fargo	Maintains	Overweight → Overweight	—	$144.56	$144.34	-0.2%	+0.2%	+1.2%	+1.0%	+1.8%	+1.0%
Apr 29	William Blair	Upgrade	Market Perform → Outperform	—	$143.33	$144.90	+1.1%	+2.1%	+0.7%	+1.4%	+1.8%	+2.4%
Apr 29	Wells Fargo	Maintains	Overweight → Overweight	—	$143.33	$144.90	+1.1%	+2.1%	+0.7%	+1.4%	+1.8%	+2.4%
Apr 29	Baird	Maintains	Outperform → Outperform	—	$143.33	$144.90	+1.1%	+2.1%	+0.7%	+1.4%	+1.8%	+2.4%
Mar 7	Wells Fargo	Maintains	Overweight → Overweight	—	$143.07	$144.50	+1.0%	+1.1%	+0.0%	-0.2%	-0.5%	-1.3%
Jan 3	Baird	Upgrade	Neutral → Outperform	—	$122.88	$125.15	+1.8%	+2.0%	+1.1%	+1.1%	+1.2%	+1.4%
Sep 11	Wells Fargo	Maintains	Overweight → Overweight	—	$125.31	$126.99	+1.3%	+1.4%	+1.0%	+0.0%	+1.2%	+0.5%
Jul 17	Wells Fargo	Maintains	Overweight → Overweight	—	$118.35	$118.40	+0.0%	+0.8%	+0.6%	+0.6%	+0.8%	+1.3%
May 1	Baird	Maintains	Neutral → Neutral	—	$118.51	$119.41	+0.8%	+2.6%	+1.7%	+1.2%	+0.2%	+2.7%
May 1	Wells Fargo	Maintains	Overweight → Overweight	—	$118.51	$119.41	+0.8%	+2.6%	+1.7%	+1.2%	+0.2%	+2.7%
May 1	Deutsche Bank	Maintains	Buy → Buy	—	$118.51	$119.41	+0.8%	+2.6%	+1.7%	+1.2%	+0.2%	+2.7%
Apr 20	BofA Securities	Maintains	Buy → Buy	—	$118.71	$119.00	+0.2%	+0.3%	+1.6%	+1.4%	-0.5%	-2.5%
Feb 21	Baird	Maintains	Neutral → Neutral	—	$116.69	$116.50	-0.2%	-1.4%	-1.7%	-1.8%	-1.6%	+0.0%
Feb 21	Wells Fargo	Maintains	Overweight → Overweight	—	$116.69	$116.50	-0.2%	-1.4%	-1.7%	-1.8%	-1.6%	+0.0%
Feb 21	Deutsche Bank	Maintains	Buy → Buy	—	$116.69	$116.50	-0.2%	-1.4%	-1.7%	-1.8%	-1.6%	+0.0%
Jan 9	Wells Fargo	Maintains	Overweight → Overweight	—	$114.06	$114.63	+0.5%	-0.6%	-0.6%	-0.5%	-0.5%	-0.1%
Nov 1	Wells Fargo	Maintains	Overweight → Overweight	—	$99.15	$99.60	+0.5%	-1.9%	-4.4%	-4.5%	-0.4%	+1.4%
Oct 18	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$97.32	$99.25	+2.0%	+2.0%	+0.9%	-1.3%	+0.2%	+0.6%
Oct 12	Wells Fargo	Maintains	Overweight → Overweight	—	$94.74	$94.76	+0.0%	-1.4%	-0.2%	+0.4%	+2.7%	+4.8%
Aug 2	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$108.20	$107.86	-0.3%	-1.5%	-0.5%	-1.6%	-2.4%	-0.9%
Aug 1	Baird	Maintains	Neutral → Neutral	—	$107.76	$106.30	-1.4%	+0.4%	-1.1%	-0.1%	-1.2%	-2.0%
Jul 18	Wells Fargo	Maintains	Overweight → Overweight	—	$100.01	$100.57	+0.6%	-1.9%	+1.0%	+1.8%	+3.5%	+3.6%
May 2	Wells Fargo	Maintains	Overweight → Overweight	—	$114.83	$115.42	+0.5%	-1.3%	-0.9%	+1.7%	-1.8%	-3.1%
Jan 20	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$121.42	$120.82	-0.5%	-2.1%	-4.2%	-3.6%	-4.4%	-5.1%
Dec 22	Wells Fargo	Maintains	Overweight → Overweight	—	$115.39	$115.05	-0.3%	+0.0%	+0.8%	+3.9%	+5.2%	+5.8%
Dec 20	Deutsche Bank	Maintains	Buy → Buy	—	$115.89	$114.82	-0.9%	-1.9%	-0.4%	-0.4%	+0.4%	+3.5%
Nov 1	Deutsche Bank	Maintains	Buy → Buy	—	$120.78	$119.98	-0.7%	+3.6%	+5.5%	+6.3%	+6.4%	+8.9%
Sep 13	Baird	Maintains	Neutral → Neutral	—	$125.84	$125.46	-0.3%	-0.9%	-1.0%	-1.0%	-2.8%	-3.7%
Aug 3	Wells Fargo	Maintains	Overweight → Overweight	—	$129.91	$129.55	-0.3%	-1.0%	-2.4%	-1.9%	-1.1%	+0.1%
Aug 2	William Blair	Downgrade	Outperform → Market Perform	—	$128.92	$128.44	-0.4%	+0.8%	-0.2%	-1.7%	-1.1%	-0.4%
May 4	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$152.46	$152.89	+0.3%	+1.7%	+1.1%	+2.7%	+3.3%	+2.0%
May 3	BMO Capital	Maintains	Outperform → Outperform	—	$150.81	$152.16	+0.9%	+1.1%	+2.8%	+2.2%	+3.8%	+4.5%

Recent Filings

8-K

AptarGroup, Inc. -- 8-K Filing

AptarGroup's Q1 2026 results declined due to emergency medicine inventory reductions and tough year-over-year comparisons in its prescription division, pressuring near-term revenue growth.

Apr 30

8-K · 5.02 !!! Very High

Unknown — 8-K 5.02: Executive Change

Athene's new CEO appointment signals leadership transition; investors should monitor strategic direction changes and management's track record executing the company's business plan going forward.

Mar 17

8-K

AptarGroup, Inc. -- 8-K Filing

AptarGroup's fourth quarter 2025 Pharma segment delivered strong growth from elastomeric components and nasal delivery technologies, signaling robust pharmaceutical market demand and positioning ATR for continued expansion.

Feb 5

Data updated apr 24, 2026 7:41pm · Source: massive.com